Search Results - "Chitta, K S"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Low expression of pro-apoptotic Bcl-2 family proteins sets the apoptotic threshold in Waldenström macroglobulinemia by Gaudette, B T, Dwivedi, B, Chitta, K S, Poulain, S, Powell, D, Vertino, P, Leleu, X, Lonial, S, Chanan-Khan, A A, Kowalski, J, Boise, L H

    Published in Oncogene (28-01-2016)
    “…Waldenström macroglobulinemia (WM) is a proliferative disorder of IgM-secreting, lymphoplasmacytoid cells that inhabit the lymph nodes and bone marrow. The…”
    Get full text
    Journal Article
  2. 2

    Suppression of the cell proliferation and invasion phenotypes in glioma cells by the LGI1 gene by KUNAPULI, Padmaja, CHITTA, Kasyapa S, COWELL, John K

    Published in Oncogene (26-06-2003)
    “…The leucine-rich, glioma-inactivated (LGI1) gene, located in 10q24, was originally identified because it was interrupted and inactivated by a reciprocal…”
    Get full text
    Journal Article
  3. 3

    In vitro plant regeneration of fig (Ficus carica L. cv. gular) using apical buds from mature trees by Kumar, V, Radha, A, Kumar Chita, S

    Published in Plant cell reports (01-06-1998)
    “…A reliable procedure for multiple-shoot induction and plantlet regeneration was developed with apical buds collected from 7- to 8-year-old trees of Ficus…”
    Get full text
    Journal Article
  4. 4

    Identification of USP14 and UCHL5 As Druggable Oncotargets in Ibrutinib-Resistant Mantle Cell Lymphoma by Paulus, Aneel, Akhtar, Sharoon, Samuel, Kelara, Yousaf, Hassan, Cogen, Davitte, Advani, Pooja, Witzig, Thomas E., Weiner, George J, Ailawadhi, Sikander, Gullbo, Joachim, Linder, Stig, Otero-Colon, Geraldo, Chitta, Kasyapa S., Chanan-Khan, Asher Alban

    Published in BLOOD (03-12-2015)
    “…Background: The clinical impact of ibrutinib is irrefutable and has been hailed as a revolutionary treatment for several cancers, including mantle cell…”
    Get full text
    Journal Article Conference Proceeding
  5. 5

    Targeted Disruption of USP14 and UCHL5 with the Novel Deubiquitinase Enzyme (DUB) Inhibitor, VLX1570, Induces Immense Proteotoxicity and Cell Death in Malignant Plasma Cells by Paulus, Aneel, Akhtar, Sharoon, Kuranz-Blake, Maja, Novak, Anne J., Ansell, Stephen, Gertz, Morie A, Kyle, Robert A, Martin, Peter, Coleman, Morton, Ailawadhi, Sikander, Linder, Stig, Chanan-Khan, Asher, Chitta, Kasyapa S.

    Published in BLOOD (06-12-2014)
    “…Background: Deubiquitinating enzyme (DUB) inhibitors are an emerging class of compounds, which are increasingly being regarded for their anti-cancer activity…”
    Get full text
    Journal Article Conference Proceeding
  6. 6
  7. 7

    Insights from Streptococcus pneumonlae glucose kinase structural model by Mulakayala, C, Banaganapalli, B N, Anuradha, C M, Chitta, S K

    Published in Bioinformation (01-01-2009)
    “…Streptococcus pneumonia is the common cause of sepsis and meningitb. Emergence of multiple antibiotic resistant strains in the community-acquired bacterium is…”
    Get full text
    Journal Article
  8. 8

    Targeted treatment for chronic lymphocytic leukemia by Masood, Aisha, Sher, Taimur, Paulus, Aneel, Miller, Kena C, Chitta, Kasyapa S, Chanan-Khan, Asher

    Published in OncoTargets and therapy (01-01-2011)
    “…The treatment of chronic lymphocytic leukemia (CLL) has evolved over the last few decades. Recognition has increased of several key components of CLL biology…”
    Get full text
    Journal Article